本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Artiva Biotherapeutics, Inc.

10.22
-0.2000-1.92%
盤後10.15-0.0700-0.68%19:30 EDT
成交量:22.84萬
成交額:234.34萬
市值:5.00億
市盈率:-3.19
高:10.61
開:10.49
低:10.10
收:10.42
52周最高:14.53
52周最低:2.22
股本:4,888.58萬
流通股本:1,927.60萬
量比:0.75
換手率:1.19%
股息:- -
股息率:- -
每股收益(TTM):-3.2084
每股收益(LYR):-3.4309
淨資產收益率:-36.58%
總資產收益率:-22.34%
市淨率:1.44
市盈率(LYR):-2.98

資料載入中...

2026/09/11

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/09/11

重要事件披露

Form 8-K - Current report
2026/09/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/28

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/10

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/06

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/06

重要事件披露

Form 8-K - Current report
2026/07/22

重要事件披露

Form 8-K - Current report
2026/05/19

重要事件披露

Form 8-K - Current report
2026/05/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/18

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/08

重要事件披露

Form 8-K - Current report
2026/05/08

[補充]招股説明書

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2026/05/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]